Advisor Group’s Windtree Therapeutics Inc WINT Stock Holding History
Bought
Maintained
Sold
Other funds holding WINT
Advisor Group's WINT Position: Q2 2017 in Review
Advisor Group sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 130 shares.
Advisor Group first reported a position in WINT in Q2 2016 and held it in 4 quarters. The position peaked at $0 in Q1 2017. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.
- Advisor Group reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
- Advisor Group sold 130 Windtree Therapeutics Inc shares in Q2 2017.
- Advisor Group first reported a position in Windtree Therapeutics Inc in Q2 2016 and held it in 4 quarters.
- Advisor Group's Windtree Therapeutics Inc position peaked at $0 in Q1 2017.
- 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.
Based on Advisor Group's 13F filing for Q2 2017, filed 11 Aug 2017.